Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Glass

Showing results (11-20 of 125) with videos related to

Pageof 13
Sort By:
Cannabis and Cannabinoid Research|September 2, 2017
Cannabinoid CB<sub>1</sub> and CB<sub>2</sub> Receptor Signaling and BiasMikkel Søes Ibsen, Mark Connor, Michelle Glass
British Journal of Pharmacology|July 2, 2010
The endocannabinoid system as a target for the treatment of neurodegenerative diseaseEmma L Scotter, Mary E Abood, Michelle Glass
CPT: Pharmacometrics & Systems Pharmacology|April 23, 2025
Development of a Heuristic Machine Analogy Method for Model Simplification With an Application to a Large-Scale Model of Gi/Gs SignalingLiang Yang, David Finlay, Michelle Glass, et al.
Frontiers in Bioscience (Landmark Edition)|March 11, 2009
Cannabinoid Receptors: A brief history and what notEuan Scott Graham, John Clive Ashton, Michelle Glass
Advances in Pharmacology (San Diego, Calif.)|August 23, 2017
Is the Cannabinoid CB<sub>2</sub> Receptor a Major Regulator of the Neuroinflammatory Axis of the Neurovascular Unit in Humans?Dan T Kho, Michelle Glass, Euan S Graham
European Journal of Pharmacology|July 25, 2024
The impact of piperazine and antipsychotic co-exposures and CB1 blockade on the effects elicited by AMB-FUBINACA, a synthetic cannabinoid, in miceLucy R Thomsen, Michelle Glass, Rhonda J Rosengren
Biochemical Pharmacology|April 11, 2024
GPCR kinase subtype requirements for arrestin-2 and -3 translocation to the cannabinoid CB<sub>1</sub> receptor and the consequences on G protein signallingJamie J Manning, David B Finlay, Michelle Glass
Cannabis and Cannabinoid Research|October 7, 2024
No Evidence for Endocannabinoid-Induced G Protein Subtype Selectivity at Human and Rodent Cannabinoid CB<sub>1</sub> ReceptorsXiaoxi Zheng, Beth Ehrlich, David Finlay, et al.
British Journal of Pharmacology|January 25, 2020
100 years of modelling ligand-receptor binding and response: A focus on GPCRsDavid B Finlay, Stephen B Duffull, Michelle Glass
Scientific Reports|June 9, 2016
Sulfation of the FLAG epitope is affected by co-expression of G protein-coupled receptors in a mammalian cell modelMorag Rose Hunter, Natasha Lillia Grimsey, Michelle Glass
Pageof 13

Showing results (11-20 of 125) with videos related to

Sort By:
Pageof 13
Cannabis and Cannabinoid Research|September 2, 2017
Cannabinoid CB<sub>1</sub> and CB<sub>2</sub> Receptor Signaling and BiasMikkel Søes Ibsen, Mark Connor, Michelle Glass
British Journal of Pharmacology|July 2, 2010
The endocannabinoid system as a target for the treatment of neurodegenerative diseaseEmma L Scotter, Mary E Abood, Michelle Glass
CPT: Pharmacometrics & Systems Pharmacology|April 23, 2025
Development of a Heuristic Machine Analogy Method for Model Simplification With an Application to a Large-Scale Model of Gi/Gs SignalingLiang Yang, David Finlay, Michelle Glass, et al.
Frontiers in Bioscience (Landmark Edition)|March 11, 2009
Cannabinoid Receptors: A brief history and what notEuan Scott Graham, John Clive Ashton, Michelle Glass
Advances in Pharmacology (San Diego, Calif.)|August 23, 2017
Is the Cannabinoid CB<sub>2</sub> Receptor a Major Regulator of the Neuroinflammatory Axis of the Neurovascular Unit in Humans?Dan T Kho, Michelle Glass, Euan S Graham
European Journal of Pharmacology|July 25, 2024
The impact of piperazine and antipsychotic co-exposures and CB1 blockade on the effects elicited by AMB-FUBINACA, a synthetic cannabinoid, in miceLucy R Thomsen, Michelle Glass, Rhonda J Rosengren
Biochemical Pharmacology|April 11, 2024
GPCR kinase subtype requirements for arrestin-2 and -3 translocation to the cannabinoid CB<sub>1</sub> receptor and the consequences on G protein signallingJamie J Manning, David B Finlay, Michelle Glass
Cannabis and Cannabinoid Research|October 7, 2024
No Evidence for Endocannabinoid-Induced G Protein Subtype Selectivity at Human and Rodent Cannabinoid CB<sub>1</sub> ReceptorsXiaoxi Zheng, Beth Ehrlich, David Finlay, et al.
British Journal of Pharmacology|January 25, 2020
100 years of modelling ligand-receptor binding and response: A focus on GPCRsDavid B Finlay, Stephen B Duffull, Michelle Glass
Scientific Reports|June 9, 2016
Sulfation of the FLAG epitope is affected by co-expression of G protein-coupled receptors in a mammalian cell modelMorag Rose Hunter, Natasha Lillia Grimsey, Michelle Glass
Pageof 13